Differences in varicella-zoster virus seroepidemiology between temperate and tropical regions

Indian Journal of Medical Sciences

Volumn 61, Issue 3, 2007, Pages 123-124

  Sauerbrei, Andreas ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VARICELLA ZOSTER VACCINE;

AGE DISTRIBUTION; ANTIBODY DETECTION; CHICKENPOX; COMPARATIVE STUDY; DEVELOPING COUNTRY; EDITORIAL; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; HERPES ZOSTER; HUMAN; INFECTION SENSITIVITY; MORTALITY; SEROEPIDEMIOLOGY; SEROPREVALENCE; SRI LANKA; TROPICS; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS TRANSMISSION;

EID: 33847792566     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.30744     Document Type: Editorial

References (6)

1. Gershon AA. The current status of live attenuated varicella vaccine. Arch Virol Suppl 2001;17:1-6.
2. Ständige Impfkommission am Robert Koch-Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2004 [In German]. Epidemiol Bull 2004;25:235-50.
3. Wutzler P, Färber I, Wagenpfeil S, Bisanz H, Tischer A. Sero-prevalence of varicella-zoster virus in the German population. Vaccine 2002;20:121-4.
4. Lokeshwar MR, Agrawal A, Subbarao SD, Chakraborty MS, Ram Prasad AV, Weil J, et al. Age related seroprevalence of antibodies to varicella in India. Indian Pediatr 2000;37:714-9.
5. Garnett GP, Cox MJ, Bundy DA, Didier JM, St Catharine J. The age of infection with varicella-zoster virus in St Lucia, West Indies. Epidemiol Infect 1993;110:361-72.
6. Liyanage NP, Fernando S, Malavige GN, Mallikahewa R, Sivayogan S, Jiffry MT, et al. Seroprevalence of varicella zoster virus infections in Colombo district, Sri Lanka. Indian J Med Sci 2007;61:128-34.